Astellas Gene Therapies remains intent on treating X-linked Myotubular Myopathy (XLMTM) through a gene therapy—but instead of AAV-based resamirigene bilparvovec (AT132), Astellas is now partnering ...

Indium values of up to 334 ppm returned: Assays confirmed above average crustal background levels (~0.1 ppm), highlighting ...

Goodyear rated Strong Buy: deep value, shift to pure-play tire model, margin & FCF upside, 383% upside estimate. Click here ...

Inovio Pharmaceuticals faces an October 30 PDUFA date for INO-3107 with high regulatory risk and only a 5-7 month cash runway. Read why INO stock is a hold.

Data retrieval and embeddings enhancements from MongoDB set the stage for a year of specialized AI - SiliconANGLE ...

Drilling is in progress at the 46 South Target located just 7 km west of Filo del Sol in the Vicuña District, at the south end of Sobek Central ...

It was the priciest biotech startup sale in North Carolina history. Now five years under Bayer, AskBio advances more AAV gene ...

Dyno Therapeutics, Inc., a genetic technologies company applying artificial intelligence (AI) to solve the grand challenge of in vivo gene delivery, today announced Dyno-yp2, a novel adeno-associated ...

ElevateBio Life Edit (R) is the Company's gene editing technologies and R&D business, focused on building the world's largest gene editing toolbox to expand addressable diseases and open a new ...

Social media has long been a valuable source of personally identifiable information (PII) for cybercriminals, but the rise of ...

CNW/ - U.S. (NASDAQ: USGO) ("U.S. GoldMining" or the "Company") is pleased to announce the initial results of the 2025 ...

Bill Rosborough and his son Jon stopped their pickup truck near a 40-acre cornfield and pointed to a white PVC pipe that rose ...